- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02785965
Acupuncture in the Regulation of Dai Meridian for Polycystic Ovarian Syndrome Patients With Abdominal Obesity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obesity, especially abdominal obesity, is one of most common clinical features of polycystic ovary syndrome, a widely and seriously influenced complex disorder related to reproduction and metabolism. Excessive accumulation of adipose tissue in the abdominal organs often leads to insulin resistance, which will increase the harm of hyperandrogenism and exacerbate ovulation disorders and metabolic abnormalities.
Weight loss, likely beneficial for both reproductive and metabolic dysfunction in this setting , has been generally recommended as a first-line therapy for obese women with PCOS and can be accomplished via lifestyle modification and electroacupuncture. What's more, stimulating acupoints of Dai Meridian can regulate menstrual cycles and treat infertility according to the theory of traditional Chinese medicine. However, how much benefits patients will additionally get from the Combined therapy is not clear now.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100078
- Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine
-
Beijing, Beijing, China, 100078
- Dongfang Hospital Affiliated to Beijing University of Chinese
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of Polycystic Ovarian Syndrome.
- Clinical diagnosis of abdominal obesity.
- Agree to participate in clinical trials.
Exclusion Criteria:
- Endocrine or neoplastic causes of amenorrhoea, anovulation and hyperandrogenemia, including central nervous system abnormalities, premature ovarian failure, thyroid disease, Cushing's syndrome,androgen secreting tumors, congenital adrenal hyperplasia, and hyperprolactinaemia.
- Patients suffering from other serious diseases(cardiocerebrovascular diseases, damage to the function of liver and kidney, and mental illness).
- Patients taking hormonal and metabolic drugs within 12 weeks of study entry affecting the judgment of results.
- Pregnant or breast feeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: acupuncture & lifestyle modification
Electro-acupuncture is given three times a week with diet restriction to 1400 calories a day and moderate aerobic exercise 3h a week for 12 weeks.
|
Disposable, single-use, sterilized stainless-steel needles (Yunlong, Beijing, China; length 40/100 mm, diameter 0.30 mm) are inserted into waist, bilaterally.
All of the six points are located in the Dai Meridian route corresponding to the ovaries.
Four needles, 0.25mm in diameter and 25mm in length, are also placed in distal acupuncture points which are located in the feet and lower arms to enhance local points' effects.
Acupuncture needles of 0.3mm in diameter and 100mm in length are inserted into GB26(Daimai) with a depth of 25-65mm by an angle of 15°, following the path of Dai Meridian (towards medial and downside).
The other needles are inserted vertically into the acupoints with a depth of 10-30mm, depending on the thickness of muscles.
Electro-acupuncture is applied to both sides of GB26 and ST25(Tianshu): cathode is connected to GB26; anode to ST25.
Needles are stimulated electrically with low frequency (2 Hz) for 20 min.
The diet restricts patients to 1400 calories a day for 12 weeks.The exercise included 12 weeks of aerobic exercise in moderate level (60 to 70% of maximum heart rate), for 3 sessions a week, each session for 60 min.
The exercises included: Warning up: 10 min, main phase (aerobic exercise): 40 min and cooling down: 10 min.
Polar Pulse measuring device from China was used to control the intensity of the exercises.
|
|
Active Comparator: lifestyle modification
diet restriction to 1400 calories a day and moderate aerobic exercise 3h a week for 12 weeks
|
The diet restricts patients to 1400 calories a day for 12 weeks.The exercise included 12 weeks of aerobic exercise in moderate level (60 to 70% of maximum heart rate), for 3 sessions a week, each session for 60 min.
The exercises included: Warning up: 10 min, main phase (aerobic exercise): 40 min and cooling down: 10 min.
Polar Pulse measuring device from China was used to control the intensity of the exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
rate of recovered ovulation
Time Frame: 12 weeks
|
the proportion of patients who have ovulation after treatment
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
evidence of clinically definite hyperandrogenism confirmed by mF-G score
Time Frame: 12 weeks
|
12 weeks
|
|
|
evidence of clinically definite hyperandrogenism confirmed by the Global Acne Grading System
Time Frame: 12 weeks
|
12 weeks
|
|
|
frequency of menstruation
Time Frame: 12 weeks
|
12 weeks
|
|
|
quantity of menstruation
Time Frame: 12 weeks
|
pictorial blood loss assessment chart
|
12 weeks
|
|
Serum total testosterone (T)
Time Frame: 12 weeks
|
12 weeks
|
|
|
FSH
Time Frame: 12 weeks
|
follicle stimulating hormone (FSH)
|
12 weeks
|
|
LH
Time Frame: 12 weeks
|
luteinizing hormone (LH)
|
12 weeks
|
|
ovarian volume measured by ultrasound
Time Frame: 12 weeks
|
12 weeks
|
|
|
follicle number pre ovary measured by ultrasound
Time Frame: 12 weeks
|
12 weeks
|
|
|
ovarian stromal blood flow measured by ultrasound
Time Frame: 12 weeks
|
12 weeks
|
|
|
body weight in kilograms
Time Frame: 4, 8 and 12 weeks
|
4, 8 and 12 weeks
|
|
|
waist circumference in centimeter
Time Frame: 4, 8 and 12 weeks
|
4, 8 and 12 weeks
|
|
|
BMI in kg/m^2
Time Frame: 4, 8 and 12 weeks
|
4, 8 and 12 weeks
|
|
|
waist-to-height ratio
Time Frame: 4, 8 and 12 weeks
|
waist-to-height ratio=waist circumference in centimeter/height in centimeter
|
4, 8 and 12 weeks
|
|
Fasting serum PAI-1 level
Time Frame: 12 weeks
|
12 weeks
|
|
|
International physical activity scale (IPAQ) short version
Time Frame: 4, 8 and 12 weeks
|
4, 8 and 12 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Hui HU, Doctor, Dongfang Hospital Beijing University of Chinese Medicine
Publications and helpful links
General Publications
- Abazar E, Taghian F, Mardanian F, Forozandeh D. Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome. Adv Biomed Res. 2015 Mar 25;4:68. doi: 10.4103/2277-9175.153892. eCollection 2015.
- Case problem: dietary recommendations to combat obesity, insulin resistance, and other concerns related to polycystic ovary syndrome. J Am Diet Assoc. 2000 Aug;100(8):955-7; discussion 957-60. doi: 10.1016/S0002-8223(00)00275-3. No abstract available.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Z161100000516057
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovarian Syndrome
-
Northwell HealthWithdrawnPolycystic Ovarian Syndrome (PCOS) | Patients Sensitive to Exogenous Gonadotropins | Ovarian Hyper Stimulation Syndrome (OHSS)United States
-
Etlik Zubeyde Hanim Womens' Health and Teaching...CompletedOvarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome
-
Wellizen AustraliaActive, not recruitingPolycystic Ovarian Syndrome (PCOS)China
-
AnnieGuard Corp.Not yet recruitingPolycystic Ovary Syndrome | PCOS | Polycystic Ovary Syndrome (PCOS) | PCOS (Polycystic Ovary Syndrome)
-
BioromaUnknownOvarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome | Invitro FertilizationItaly
-
Muhammad Aamir LatifCompletedPolycystic Ovarian SyndromePakistan
-
University of Health Sciences LahoreNot yet recruitingPregnancy Outcomes | Polycystic Ovarian Syndrome (PCOS)
-
Bruce LesseyTerminatedPolycystic Ovarian SyndromeUnited States
-
Kufa UniversityCompletedPolycystic Ovary SyndromeIraq
-
Duke UniversityTerminatedPolycystic Ovarian SyndromeUnited States
Clinical Trials on electroacupuncture
-
Kaiyang ZhengQinghai People's HospitalNot yet recruitingLimb Dysfunction in Ischemic Stroke Patients at High-Altitude Regions
-
The Second Affiliated Hospital, Guangzhou University...RecruitingDisorder of Consciousness | ElectroacupunctureChina
-
Guang'anmen Hospital of China Academy of Chinese...Shenzhen Second People's Hospital; Shaanxi Hospital of Traditional Chinese... and other collaboratorsUnknown
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Guang'anmen Hospital of China Academy of Chinese...Not yet recruitingElectroacupuncture | Menstrually Related MigraineChina
-
Guang'anmen Hospital of China Academy of Chinese...RecruitingMedication Overuse Headache | ElectroacupunctureChina
-
Guang'anmen Hospital of China Academy of Chinese...RecruitingDysmenorrhea | Adenomyosis | ElectroacupunctureChina
-
Guang'anmen Hospital of China Academy of Chinese...RecruitingChronic Urinary RetentionChina
-
Guang'anmen Hospital of China Academy of Chinese...Ministry of Science and Technology of the People´s Republic of ChinaCompletedMenopausal SyndromeChina
-
Yi LiangZhejiang Provincial Department of Science and TechnologyRecruitingFunctional DyspepsiaChina